B-vitamins · Gummies

Choline Bitartrate

Choline Bitartrate is a water-soluble salt form of choline, an essential nutrient involved in neurotransmitter synthesis, cell membrane structure, and lipid metabolism. It is one of the most familiar and commercially understood gummy actives across EU and US markets. Choline does not carry EFSA-authorised health claims under Reg. (EU) 432/2012, so claim coverage relies on co-formulated nutrients.

brain-health
cognitive-support
prenatal-health

Build a formula with this ingredient

At a glance

Definition: Choline Bitartrate is a water-soluble salt form of choline, an essential nutrient involved in neurotransmitter synthesis, cell membrane structure, and lipid metabolism. It is one of the most familiar and commercially understood gummy actives across EU and US markets. Choline does not carry EFSA-authorised health claims under Reg. (EU) 432/2012, so claim coverage relies on co-formulated nutrients.
Authorised wording (summary): 2 authorised statements — see "US structure-function statements" below.
Common positionings: cognitive function
memory support
prenatal nutrition
liver health
energy metabolism
Format suitability: Reviewed for gummies and sachets — confirmed per project.

Format & category fit

Where this ingredient fits in the DAT Supply catalogue

Every format chip links through to its manufacturing hub and to the private-label catalogue for that format. The category chip routes to the matching vertical hub on the categories index.

Available in

Positioning

Vitamins & minerals
Browse all ingredients

What it is

Choline Bitartrate is a salt form of choline, an essential nutrient that the body requires for several fundamental processes. It is a precursor to acetylcholine, a neurotransmitter critical for memory and muscle control, and it also plays a role in methyl-group donation and lipid transport in the liver. As a nutrient, choline is grouped with the B-vitamin family due to its similar metabolic functions, though it is not technically a vitamin.

Brands use Choline Bitartrate in gummy supplements to target cognitive health, memory support, and prenatal nutrition. It is a well-recognised ingredient among consumers seeking brain health and nervous system support. Because choline does not have EFSA-authorised health claims, brands typically position it alongside co-formulated nutrients such as Vitamin B6, Vitamin B12, or Magnesium to support nervous system function.

Origin and history

Choline was first isolated from ox bile in 1862 by the German chemist Adolph Strecker. Its essential role in human nutrition was established throughout the 20th century, and it was officially recognised as an essential nutrient by the Institute of Medicine in 1998. Choline Bitartrate became a common supplemental form due to its good water solubility and stability.

Industrially, Choline Bitartrate is produced by reacting choline with tartaric acid. The resulting salt is a white crystalline powder that is odourless and stable under normal storage conditions. It is widely used in food supplements, infant formula, and pharmaceutical applications.

Scientific overview

Choline is a precursor to the neurotransmitter acetylcholine, which is essential for memory, mood, and muscle control. It also contributes to the structural integrity of cell membranes as a component of phosphatidylcholine, and it supports lipid metabolism in the liver by facilitating the export of triglycerides. The body can synthesise some choline, but dietary intake is required to meet physiological needs.

Choline Bitartrate is a highly bioavailable form of choline. It is water-soluble and readily absorbed in the small intestine. Compared to other forms such as choline citrate or choline chloride, the bitartrate salt offers a good balance of solubility, stability, and cost. It is heat-stable, making it suitable for gummy manufacturing without significant degradation during processing.

From a manufacturing perspective, Choline Bitartrate is soluble in gummy formulations and does not present major processing challenges. However, at higher doses (above approximately 150 mg per serving), it can impart a fishy taste that requires significant masking with flavours, sweeteners, or encapsulation. The cost per milligram is moderate, making it a viable option for mid-tier product positioning.

Why brands use Choline Bitartrate

Choline Bitartrate is positioned primarily in cognitive health, memory support, and prenatal nutrition ranges. It is one of the most familiar and commercially understood gummy actives across EU and US markets. Brands targeting students, professionals, and older adults often include choline in brain-health formulations, while prenatal brands use it for foetal brain development support. The ingredient also appears in liver health and energy metabolism products.

From a formulation perspective, Choline Bitartrate is heat-stable and water-soluble, which simplifies gummy manufacturing. The main challenge is taste masking at higher doses. Brands must invest in robust flavour systems — typically fruit flavours like berry or citrus — to overcome the fishy note. The ingredient is compatible with most gummy bases and does not require special processing equipment. DAT confirms the final formulation and taste profile per project.

For pack copy, brands should avoid disease claims and unsubstantiated structure-function language in EU markets. Because choline has no EFSA-authorised health claims, any claim positioning must be supported by co-formulated nutrients with authorised claims. For example, a gummy containing both Choline Bitartrate and Vitamin B6 could carry the claim "Vitamin B6 contributes to normal functioning of the nervous system" under Reg. (EU) 432/2012. DAT reviews claim strategy per project and confirms compliance before final label approval.

Supported formats

Formats this ingredient is reviewed for

DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.

Formulation notes

Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.

Gummy fit: Limited
Heat stable: Yes
Soluble in matrix: Yes
Cost tier: Medium

Forms available

Choline Bitartrate, Choline Citrate, Choline Chloride

Dosage reference

Choline does not have an established reference-intake target reviewed per market. Typical brand positioning ranges from 50 mg to 250 mg per serving. DAT confirms the final dose per project based on target market, format, and claim strategy.

Taste & sensory

Fishy taste at higher doses. Significant masking needed.

Manufacturing notes

No specific formulation notes. Standard processing applies.

Format considerations

Per-format formulation notes

Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.

Gummies

Taste masking and aroma load against the cooked-base flavour — confirmed per project.
Heat exposure during cooking; coated or encapsulated forms may be required — confirmed per project.
Matrix choice (pectin vs gelatin) and its effect on ingredient stability — confirmed per project.
Per-gummy dose and serving count needed to hit the label claim — confirmed per project.

Develop in gummies →

Sachets

Powder flow and dose accuracy at single-serve sachet weights — confirmed per project.
Barrier requirements (oxygen, moisture) for the active — confirmed per project.
Reconstitution behaviour when the sachet is dosed into water — confirmed per project.

US structure-function statements

Choline is a source of methyl groups needed for normal homocysteine metabolism.Structure-function (DSHEA)
Choline is a precursor to the neurotransmitter acetylcholine, which supports normal cognitive function.Structure-function (DSHEA)

Structure-function statements must appear with the FDA disclaimer in the same field of vision on the label. % Daily Value (DV) based on FDA 21 CFR 101.9.

Wording to avoid on pack copy

No disease claims (diagnose, treat, cure, or prevent any disease).
Structure-function claims must be accompanied by the FDA disclaimer: 'These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.'
No certification promises on pack until confirmed per project and batch.
No guaranteed shelf-life on pack until confirmed with stability data.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Structure-function claims are permitted under DSHEA (21 USC §343(r)(6)). Choline does not have an established Daily Value (DV) under FDA 21 CFR 101.9.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.